Equity Research, Broker Reports, and media content on ValiRx PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ValiRx PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

ValiRx PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ValiRx PLC. We currently have 119 research reports from 10 professional analysts.

  • Open: 2.40p
  • Range Today: 2.36/2.43p
  • 52 Week: 1.85/15.0p
  • Daily Volume: 4.0k
  • Daily Liquidity: 0.00%
  • # Shares: 132.3m
  • Market Cap: £3.18m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
03Jul24 08:51 RNS ValiRx PLC - Proposed Director Appointment
20Jun24 17:56 RNS ValiRx PLC - Result of AGM
19Jun24 11:33 RNS ValiRx PLC - Directorate Change
17Jun24 07:00 RNS ValiRx PLC - Inaphaea Contract Award
28May24 07:00 RNS ValiRx PLC - Investor Webinar
20May24 12:00 RNS ValiRx PLC - Business Update
16May24 07:00 RNS ValiRx PLC - Further re Final Results
  • Frequency of research reports


  • Research reports on

    ValiRx PLC

  • Providers covering

    ValiRx PLC

ValiRx PLC is a life science company with a focus on clinical-stage drug development. The company trades under the ticker Lon:VAL

Frequently asked questions